FIG4 is a ubiquitously expressed phosphatase that, in complex with FAB1/PIKFYVE and VAC14, regulates the biosynthesis of the signaling lipid PI(3,5)P 2 . Null mutation of Fig4 in the mouse results in spongiform degeneration of brain and peripheral ganglia, defective myelination and juvenile lethality. Partial loss-of-function of human FIG4 results in a severe form of Charcot -Marie-Tooth neuropathy. Neurons from null mice contain enlarged vacuoles derived from the endosome/lysosome pathway, and astrocytes accumulate proteins involved in autophagy. Other cellular defects include astrogliosis and microgliosis. To distinguish the contributions of neurons and glia to spongiform degeneration in the Fig4 null mouse, we expressed Fig4 under the control of the neuron-specific enolase promoter and the astrocyte-specific glial fibrillary acidic protein promoter in transgenic mice. Neuronal expression of Fig4 was sufficient to rescue cellular and neurological phenotypes including spongiform degeneration, gliosis and juvenile lethality. In contrast, expression of Fig4 in astrocytes prevented accumulation of autophagy markers and microgliosis but did not prevent spongiform degeneration or lethality. To confirm the neuronal origin of spongiform degeneration, we generated a floxed allele of Fig4 and crossed it with mice expressing the Cre recombinase from the neuron-specific synapsin promoter. Mice with conditional inactivation of Fig4 in neurons developed spongiform degeneration and the full spectrum of neurological abnormalities. The data demonstrate that expression of Fig4 in neurons is necessary and sufficient to prevent spongiform degeneration. Therapy for patients with FIG4 deficiency will therefore require correction of the deficiency in neurons.
INTRODUCTION
Spongiform degeneration of the brain is characterized by accumulation of vacuoles between 1 and 50 mm in diameter and a unique histological appearance. The best-known cause of spongiform degeneration in human brain is prion infection, although recent evidence suggests that a similar process may be involved in more common neurodegenerative disorders (1) . Mouse mutants of Atrn and Mgrn1 in the endocytic pathway result in spongiform degeneration of the brain with a variable age of onset depending on the specific mutation (2) (3) (4) . Pathogenesis in the Mgrn1 mutant may be mediated by altered ubiquitination of the endosomal sorting protein TSG101 (5) . An early onset, severe spongiform degeneration of the central nervous system (CNS) is also characteristic of mutations in the endolysosomal proteins FIG4, VAC14 and PIKFYVE/ FAB1, which interact in a complex involved in biosynthesis of PI(3,5)P 2 (6) (7) (8) (9) . In addition to their effect in the CNS, these mutations also result in spongiform degeneration of the dorsal root ganglia (DRG) and other peripheral ganglia.
Fig4 encodes a ubiquitously expressed lipid phosphatase that regulates intracellular abundance of the signaling phospholipid PI(3,5)P 2 . Deficiency of PI(3,5)P 2 impairs turnover of cell components in the yeast vacuole (10 -12) and the mammalian endosome/lysosome system (9,13 -15) . Cellular abnormalities in the Fig4 null mouse include neurodegeneration (6) , astrocytosis with accumulation of autophagy intermediates (8, 14) , microgliosis (14) , and hypomyelination of † These authors made equal contributions. * To whom correspondence should be addressed at: Department of Human Genetics, 4909 Buhl Box 5618, University of Michigan, Ann Arbor, MI 48109-5618, USA. Tel: +1 7347635546; Fax: +1 7347639691; Email: meislerm@umich.edu # The Author 2012. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com Human Molecular Genetics, 2012, Vol. 21, No. 16 3525-3534 doi:10.1093/hmg/dds179 Advance Access published on May 11, 2012 the CNS and peripheral nervous system (PNS) (6, 16, 17) . The relationships among these distinct pathologies are unclear.
Patients with the peripheral neuropathy Charcot -Marie -Tooth Type 4J (OMIM 611228) are compound heterozygotes carrying a null allele of FIG4 and a partial-loss-of-function missense mutation (6, 18) . The most common missense mutation, Ile41Thr, has an allele frequency of 0.001 in European populations (18) and causes protein instability due to the loss of interaction with the scaffold protein VAC14 (19) . The estimated 1% of normal level of FIG4-I41T protein in CMT4J cells (19) is sufficient to protect the CNS, but in the PNS there is a reduced number of myelinated axons with abnormally thin myelination, resulting in slowed nerve conduction velocity (16, 18) . Many patients with this rare form of Charcot -Marie -Tooth disease, experience progression to wheelchair dependence and death.
The current work was undertaken to elucidate the relationships among the pathogenic effects of Fig4 deficiency in neurons, astrocytes, microglia and myelinating Schwann cells. We generated transgenic mouse models expressing tissue-specific 
RESULTS

Rescue of the Fig4 null phenotype by a neuron-specific transgene
The mouse Fig4 cDNA was cloned downstream of the 4 kb promoter fragment from the rat neuron-specific enolase (NSE) gene (20-23) ( Fig. 1A 
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3 and 4 months of age are shown in Supplementary Material, Videos S1 and S2. Histological examination of the brain at 3 weeks of age demonstrated a correction of spongiform degeneration in the cortex, cerebellum, hippocampus and brainstem of Fig. S2C ). Spongiform degeneration of the DRG was also prevented by the NSE-Fig4 transgene (Fig. 2 ). We carried out western blot analysis to evaluate the abundance of proteins that accumulate in astrocytes of Fig4 null brain due to defective autophagy: lysosomal membrane proteins LAMP-1 and LAMP-2, autophagy markers LC3-II and p62 and astrocyte intermediate filament glial fibrillary acidic protein (GFAP) (14) . Accumulation of these markers was largely corrected in the (Fig. 3B ). There is no additional accumulation of these markers at 9 months of age (Supplementary Material, Fig. S2D ). The small amount of LAMP-1 accumulation in the transgenic brain is co-localized with p62, as it is in Fig4 null mice (Supplementary Material, Fig. S3 ) (14) . The level of IBA-1 in brain, a marker of microgliosis, was also corrected by neuronal expression of Fig4 (Fig. 3A) .
Sciatic nerve conduction velocity is reduced to 50% of wild-type in 
Generation of a floxed allele of Fig4
To confirm the neuronal basis of spongiform degeneration, we generated a floxed allele of Fig4 by targeted germline mutation in ES cells. LoxP sites were introduced flanking the 157 bp exon 4 ( Fig. 7A, Supplementary Material, Fig. S1C) and targeting was confirmed by Southern blotting of ES cell DNA ( Supplementary Material, Fig. S1D ). The function of the floxed allele was tested using the ubiquitously expressed E2A-Cre transgene (Jackson Laboratory stock 003724). Crosses were carried out as described in Materials and Methods. The phenotype of Fig4 flox/flox , E2a-Cre offspring reproduced the phenotype of Fig4 null mice, including small size ( Fig. 7B) , tremor, and early lethality. Fig4 transcripts from the conditionally ablated allele did not contain exon 4 (Fig. 7A ). FIG4 protein was not detected by western blotting (Fig. 7C) . Thus, the phenotype of the 
Neuron-specific inactivation of Fig4 results in spongiform degeneration
To determine whether expression of Fig4 in neurons is necessary to prevent spongiform degeneration, we generated In the tail suspension test for neurodegeneration, at 3 months of age, the transgenic mice consistently exhibited extreme clasping of both hindlimbs and forelimbs, in contrast to the normally splayed limbs of wild-type littermates ( Fig. 8B) . Histologically, extensive spongiform degeneration is evident in the deep layers of the cortex, in cerebellar nuclei, 
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hippocampus, brainstem and DRG at 1 month of age ( Fig. 8C ). CNS hypomyelination in the Syn-Cre mice is indicated by the deficiency of MBP on western blots of brain extracts, comparable with the deficiency in global Fig4 null mice (Fig. 8D ).
Composite saggital brain sections demonstrate that the distribution of degeneration in the Syn-Cre mice is comparable with that in Fig4 null mice ( Supplementary Material,  Fig. S4A ). Thus, the widespread spongiform neurodegeneration in the CNS and PNS of Syn-Cre mice recapitulates the behavioral and histopathological features of the global null mice. In contrast, there was no evidence of astrocyte dysfunction in the Syn-Cre mice, as demonstrated by the lack of inclusion bodies immunostained for LAMP-1 and GFAP in cortical slices (Fig. 8E ) and the normal level of p62 in brain at 30 days (Fig. 8F) .
Despite the severe neurological dysfunction in ( Supplementary Material, Fig. S4B and C) . Coat color is not diluted in Syn-Cre mice, consistent with the lack of rescue of coat color by the NSE-Fig4 transgene.
DISCUSSION
By a combination of transgenic and knock-out approaches, we have demonstrated that expression of Fig4 in neurons is both necessary and sufficient to prevent spongiform degeneration in the brain and peripheral ganglia. The long-term survival of Fig4 null mice expressing the NSE-Fig4 transgene demonstrates that expression in neurons is sufficient to prevent the severe neurological disorder seen in uncorrected Fig4 null mice. Conversely, synapsin-Cre mice lacking Fig4 expression in neurons are severely affected, with spongiform degeneration of the brain at 30 days of age that is comparable with that of the global Fig4 null mutant. Neuronal disease is thus cell-autonomous, and is sufficient to initiate spongiform degeneration. The sensitivity of neurons to Fig4 deficiency is reminiscent of lysosomal storage diseases, which also result from deficiency of ubiquitously expressed genes with severe consequences in neurons. For example, there is neuronal cell autonomous degeneration in mouse models of Niemann Pick Disease type C, based on transgenic and knockout experiments similar to those reported here (22, 23) . It may be appropriate to consider Fig4 deficiency to be a lysosomal disorder, in view of the localization of PI(3,5)P 2 in late endosomal and lysosomal membranes, and its role in regulation of the lysosomal cation channel TRPML1 (24; discussed in 19, 25) . Impaired cation transport could lead to perturbed lysosomal calcium homeostasis (26) , resulting in an abnormal intralysosomal milieu with incomplete substrate digestion and the observed block in the resolution of autolysosomes in Fig4 null mice (14) .
Correction of the autophagy defect in astrocytes was observed in GFAP-Fig4 transgenic mice and in synapsin-Cre KO mice, but this did not prevent the development of spongiform degeneration and neurological disease. This contrasts with the situation in mouse models of SOD1-dependent ALS, where neuronal degeneration is affected by astrocyte genotype in mixed cell cultures and in vivo (27) (28) (29) (30) (31) (32) . Astroctyes in Fig4 null mice exhibit extensive accumulation of autophagy intermediates, ubiquinated proteins and lysosomal membrane proteins, with a 3× excess in whole-brain extracts (14) . This now appears to be a secondary phenotype that is not an essential component of clinical disease. Fig4 expression in either neurons or astrocytes prevents the astrocyte protein accumulation. Thus the astrocyte autophagy defect requires Fig4 deficiency both in neurons (a source of extracellular signals) as in astrocytes. In our experiments, development of microgliosis requires Fig4 deficiency in three cell types: neurons, astrocytes and microglia. However, it will be necessary to examine additional models with conditional inactivation of Fig4 in glial cells to determine whether there is a cell autonomous role of Fig4 in these cells.
Defects in maturation of oligodendrocyte precursors and myelination of CNS axons are corrected by expression of the NSE-Fig4 transgene (17) . Defective myelination of the sciatic nerve also appears to be improved in Fig4 2/2 , NSE-Fig4 mice, although the mechanism is not known.
The demonstration of the major neuronal contribution to the central and peripheral defects associated with Fig4 deficiency indicates that neuronal targeting will be required for treatment of patients with Charcot -Marie -Tooth type 4J.
MATERIALS AND METHODS
Transgenic mice
The 4 kb NSE promoter that includes 2.8 kb of upstream sequence through exon 2 of the rat Eno2 gene has been widely used to direct neuron-specific transgene expression (e.g. [33] [34] [35] [36] . The wild-type Fig4 cDNA fragment containing 121 bp of Fig4 5 ′ UTR and 2721 bp of coding sequence was amplified from a previously described transgene clone (19) and cloned into the NSE vector by addition of HindIII sites (37 and Supplementary Material, Fig. S1A ). The human Gfa2 (GFAP) promoter contains 2.2 kb of upstream sequence and 46 bp from exon 1 (20) . The initiating ATG codon in the GFAP fragment was mutated to TTG to permit translation initiation in the Fig4 cDNA. The 3 ′ UTR and polyadenylation signal in this construct are derived from the mouse protamine 1 gene (Prm-1) (20) .
Linearized and gel-purified transgene constructs were microinjected into (C57BL/6 × SJL)F2 fertilized eggs in the University of Michigan Transgenic Animal Core (www.med. umich.edu/tamc/). Transgenic founders carrying both constructs were identified by PCR with a forward primer from Fig4 exon 4 (5 ′ -TACCG TGCGA AAACC AGATG-3 ′ ) and a reverse primer from exon 5 (5 ′ -CACAG GAGTG GATCG CTGAG-3 ′ ). Nine independent founders carrying each transgene were crossed with CB. Fig4 +/ 2 heterozygous mice carrying the pale tremor null allele of Fig4 (5, 19) . Fig4 +/ 2 transgenic offspring were crossed with Fig4 +/ 2 heterozygotes to generate Fig4 2/ 2 transgenic mice for experiments. Expression of each transgene on the wild-type or Fig4 +/ 2 heterozygous background did not cause visible abnormalities or reduced fertility. Experiments were carried out between 3 and 4 weeks of age unless otherwise specified, using Fig4 2/ 2 transgene-negative littermates as null controls. For survival studies, moribund animals were sacrificed when locomotor deficits impaired feeding or drinking. Animals were housed and cared for in accordance with NIH guidelines. Experiments were approved by the University of Michigan Committee on the Use and Care of Animals.
Generation of a floxed allele of Fig4 by gene targeting in ES cells
The 157 bp exon 4 of Fig4 was selected for targeting to avoid disrupting conserved noncoding sequences in earlier introns. In addition to exon 4, the targeting construct contained 2.6 kb of upstream sequence from intron 3, 1.7 kb of downstream sequence from intron 4 and the selectable neomycin resistance cassette (see Supplementary Material). Gene targeting in R1 mouse embryonic stem cells was performed by the University of Michigan Transgenic Animal Core as described (38) . Neomycin resistant colonies were screened by Southern blotting to detect 5 ′ and 3 ′ insertion site junctions Only female SynCre transgenic mice were used for breeding, because the transgene is active in the male germline (39) .
Quantitative RT -PCR
qRT -PCR was carried out as described (19) . RNA was prepared using the Trizol reagent (Invitrogen) and cDNA was generated with the first-strand cDNA synthesis kit (Invitrogen). Transgene expression on the Fig4 null background was detected using the Applied Biosystems pre-designed assay spanning the junction between Fig4 exons 18 and 19 (catalog # Mm 01189585_m1). Since interruption of intron 18 by retrotransposon insertion in the Fig4 plt null allele prevents splicing from exons 18 to 19 in the null transcript (6), RNA from null mice was used as a negative control.
Histology, immunostaining and western blotting
The brain and spinal cord were immersion fixed for 24 h at 48C in phosphate-buffered 10% formalin and then in 70% ethanol for an additional 24 h at 48C. Paraffin embedding and H&E staining were carried out at Histoserv Inc. (Bethesda, MD, USA). Images were obtained with an Olympus BX51 microscope and DP50 camera. Western blotting was carried out as previously described for p62, LC3-II, LAMP-1, LAMP-2, GFAP, IBA-1 (14) , FIG4 (19) and MBP (17) . Immunostaining for LAMP-1, p62, NeuN and GFAP in fresh frozen brain sections was carried out as described (14) . Images were captured on an Olympus BX51 microscope equipped with epifluorescence and an Olympus DP-70 digital camera before being processed and merged using Adobe Photoshop. Sciatic nerve sections were prepared and analyzed as previously described (17) .
Peripheral nerve structure and function
Sciatic-tibial motor nerve conduction velocity and sural sensory nerve conduction velocity were measured as previously described (19) . Electron microscopy of sciatic nerve axons was carried out as previously described (19) .
